正电子发射断层摄影术
肺癌
PD-L1
免疫组织化学
医学
核医学
标准摄取值
癌症
肺
病理
癌症研究
肿瘤科
内科学
免疫疗法
作者
Anna-Larissa Nadia Niemeijer,David Ka-Wai Leung,Marc C. Huisman,Idris Bahce,Otto S. Hoekstra,Guus A.M.S. van Dongen,Ronald Boellaard,Shuyan Du,Wendy Hayes,R. Smith,Albert D. Windhorst,N. Harry Hendrikse,Alex J. Poot,Daniëlle J. Vugts,Erik Thunnissen,Paul E. Morin,Daša Lipovšek,David J. Donnelly,Samuel J. Bonacorsi,Lauren Velasquez
标识
DOI:10.1038/s41467-018-07131-y
摘要
PD-L1 immunohistochemistry correlates only moderately with patient survival and response to PD-(L)1 treatment. Heterogeneity of tumor PD-L1 expression might limit the predictive value of small biopsies. Here we show that tumor PD-L1 and PD-1 expression can be quantified non-invasively using PET-CT in patients with non-small-cell lung cancer. Whole body PD-(L)1 PET-CT reveals significant tumor tracer uptake heterogeneity both between patients, as well as within patients between different tumor lesions.
科研通智能强力驱动
Strongly Powered by AbleSci AI